Form D · Pharmaceuticals

Apicore Inc.

Somerset, NJ · CIK 0001613021

Offering snapshot reported Oct 7, 2016 · SEC filing

Reported sold
$720K
Offering amount: $720K
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 26, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 7, 2016Initial$720,118No comparison4SEC filing
Jul 15, 2014Initial$12,500No comparison12SEC filing
Jul 15, 2014Initial$9,200,037No comparison2SEC filing
Jul 15, 2014Initial$6,826,400No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-272018

Source: Form D, filed Oct 7, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Vithal Dahduk Director
Vithal Dhaduk Director
Albert Friesen Director, Executive
James Gale Executive
Ravishanker Kovi Director, Executive
Theron E. Odlaug Director
Timothy B. Sawyer Director
Todd Sone Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
49 Napoleon Court, Worlds Fair Drive
Somerset, NJ, 08873